PolyPid to Report Third Quarter 2021 Financial Results and Operational Highlights on November 10, 2021

PETAH TIKVA, Israel, Nov. 01, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, today announced that